SEC Form 4 · accession 0001493152-17-010718
Microbot Medical Inc. · MBOT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harel Gadot
Officer — President, CEO and Chairman · Director · 10% Owner
Period of report
Sep 14, 2017
Accepted (ET)
Sep 18, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883975
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.05 | Sep 14, 2017 | A | 1,336,522 | A | — | Sep 14, 2027 | Common Stock, par value $0.01 per share | 1,336,522 | 1,336,522 | D |
| Stock Option (Right to Buy)F2 | $1.05 | Sep 14, 2017 | A | 476,190 | A | — | Sep 14, 2027 | Common Stock, par value $0.01 per share | 476,190 | 476,190 | D |
Explanation of responses
- F1The options vest as follows and in accordance with the terms of the Issuer's Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.
- F2The options vest equally on an annual basis over 60 months commencing on the one year anniversary of the date of grant, and in accordance with the terms of the Issuer's Equity Incentive Plan.